Skip to main content
    I

    ICU Medical Inc (ICUI)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $181.87
    +2.60 (+1.45%)

    Market Cap: $4.48B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    ICU Medical Inc (ICUI) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    ICU Medical (ICUI) trades at 22.7x trailing earnings and 2.1x sales. Its P/E of 22.7x is above its 5-year median of 21.6x. Its forward P/E is 18.3x. The median P/E across 10 similar companies is 20.1x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 24.0% higher over the next year. Its free cash flow yield is 4.6%.

    MultipleValue
    P/E (trailing)22.7x
    Forward P/E18.3x
    Price to sales2.1x
    Price to book2.1x
    EV/EBITDA16.6x
    Price to FCF21.8x
    EV/FCF25.9x
    PEGN/A
    FCF yield4.6%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 13.0% below 26.1x, its P/S is 30.0% below 3.0x and its P/B is 16.0% below 2.5x.

    MultipleCurrent5-year median10-year median
    P/E22.7x21.6x26.1x
    P/S2.1x1.7x3.0x
    P/B2.1x1.8x2.5x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 14.8x in 2023 to 33.0x in 2017.

    Year endPriceP/EP/SP/B
    2025$142.6719.5x1.6x1.7x
    2024$155.1724.9x1.6x1.9x
    2023$99.7414.8x1.1x1.1x
    2022$157.4824.1x1.6x1.8x
    2021$237.3432.1x3.8x3.2x
    2020$214.4930.1x3.6x3.1x
    2019$187.1222.9x3.1x2.9x
    2018$229.6326.0x3.3x3.7x
    2017$216.0033.0x3.3x3.8x
    2016$147.3530.4x6.4x3.9x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About ICUI

    What is ICUI's forward P/E ratio?

    ICU Medical has a forward P/E ratio of 18.3x.

    Is ICUI stock overvalued?

    GNG's valuation label for ICUI is Fairly valued. Its P/E of 22.7x compares with a median of 20.1x across 10 similar companies.

    What is ICUI's price to sales ratio?

    ICU Medical has a price to sales ratio of 2.1x.

    What is ICU Medical's average P/E ratio over 5 years?

    ICU Medical's median P/E over the last 5 years is 21.6x, from 60 month-end values through Oct 2026.